DexCom Inc (DXCM)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 4,425,900 | 3,668,800 | 3,684,400 | 3,424,800 | 1,969,400 |
| Total current liabilities | US$ in thousands | 1,556,000 | 1,839,300 | 720,800 | 614,100 | 360,200 |
| Current ratio | 2.84 | 1.99 | 5.11 | 5.58 | 5.47 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $4,425,900K ÷ $1,556,000K
= 2.84
The current ratio of Dexcom Inc has demonstrated some variability over the past five years.
In 2023, the current ratio stands at 2.84, which indicates that Dexcom has $2.84 in current assets for every $1 in current liabilities. This represents an improvement from the previous year, where the current ratio was 1.99.
Comparing to the figures from 2021, 2020, and 2019, it is evident that Dexcom had significantly higher current ratios in those years, with ratios of 5.11, 5.58, and 5.47 respectively. This suggests that in those years, Dexcom had a stronger ability to cover its short-term obligations with its current assets.
Overall, while Dexcom's current ratio has fluctuated, it remains above 1, indicating that the company has had sufficient current assets to cover its current liabilities in all the years presented. However, investors and analysts may want to monitor the trend in the current ratio to assess Dexcom's liquidity position over time.
Peer comparison
Dec 31, 2023